BIO-RAD LABORATORIES, INC. (BIO) Return on equity 2016–2025
BIO-RAD LABORATORIES, INC. (BIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
10.2%FY2025 · since FY2016: 1.0% → 10.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.2% | +38.3 pp |
| FY2024 | -28.1% | -20.8 pp |
| FY2023 | -7.3% | +30.4 pp |
| FY2022 | -37.7% | -68.8 pp |
| FY2021 | 31.1% | -7.5 pp |
| FY2020 | 38.6% | +8.0 pp |
| FY2019 | 30.5% | +21.5 pp |
| FY2018 | 9.1% | +4.9 pp |
| FY2017 | 4.2% | +3.2 pp |
| FY2016 | 1.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice